Tirzepatide has shown the largest results so far, with average reductions ranging from 15% to nearly 21% over 72 weeks, depending on dose
Aortic stenosis is a common heart valve condition that restricts blood flow from the heart, causing chest pain, fatigue, and shortness of breath
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily licensed in the UK for managing type 2 diabetes mellitus and, in some cases, obesity
This also adds to the ability to lose weight, also because of the slower gastric emptying
The remaining four outcomes were rated high
The key theme across all Melanotan 1 research is precision